| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.06 |